Dupilumab Subcutaneous and Glycate Tablets
Determining the interaction of Dupilumab Subcutaneous and Glycate Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: glycopyrrolate
Brand name: Cuvposa, GLYRX-PF, Robinul, Robinul Forte, Lonhala Magnair Starter Kit, Seebri Neohaler
Synonyms: Glycopyrrolate, Glycopyrrolate (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Glycerin and Lidocaine
- Dupilumab Subcutaneous-Glycerin Enema
- Dupilumab Subcutaneous-Glycerin rectal
- Dupilumab Subcutaneous-Glycerin Suppositories
- Dupilumab Subcutaneous-Glycerol phenylbutyrate
- Dupilumab Subcutaneous-GlycoLax
- Glycate Tablets-Dupixent
- Glycate Tablets-Duplex T Topical
- Glycate Tablets-Durachol
- Glycate Tablets-Duraclon
- Glycate Tablets-Duraclon injection
- Glycate Tablets-Duraflu